Single-cell transcriptional profiling reveals a novel RAB13+ endothelial subpopulation and profibrotic mesenchymal cells in the aged human bone marrow
Itziar Cenzano,
No information about this author
Miguel Cócera,
No information about this author
A. Perez
No information about this author
et al.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 29, 2025
ABSTRACT
The
bone
marrow
(BM)
microenvironment
plays
a
crucial
role
in
regulating
hematopoiesis,
yet
the
molecular
and
functional
changes
associated
with
aging
humans
remain
poorly
understood.
Using
single-cell
RNA
sequencing
(scRNA-seq),
we
uncovered
transcriptional
shifts
BM
endothelial
cells
(EC)
mesenchymal
stem
(MSC)
during
aging.
Our
analysis
revealed
that
aged
sinusoidal
EC
adopt
prothrombotic,
exhibit
mitochondrial
dysfunction,
have
compromised
vascular
function.
Additionally,
identified
unique
arterial
subset,
present
only
individuals,
elongation
senescence
processes
characterized
by
RAB13
expression.
MSC
from
subjects
displayed
an
impaired
matrix
remodeling
epithelial-mesenchymal
transition,
driven
partly
subpopulation
of
THY1
+
profibrotic
stromal
absent
young
subjects.
Aged
were
also
increased
ATP-oxidative
metabolism
reduced
protein
folding
capacity.
Finally,
using
immunofluorescent
imaging
spatial
transcriptomics,
confirmed
presence
senescent
samples
significant
age-related
cell-cell
communication
within
niche.
In
summary,
this
work
provides
comprehensive
view
diversity,
cellular
interactions,
organization
MSC,
offering
novel
insights
potential
targets
could
be
exploited
for
preventing
aged-associated
humans.
Language: Английский
Mesenchymal stromal cells in bone marrow niche of patients with multiple myeloma: a double-edged sword
Sina Kamrani,
No information about this author
Reza Naseramini,
No information about this author
Pouria Khani
No information about this author
et al.
Cancer Cell International,
Journal Year:
2025,
Volume and Issue:
25(1)
Published: March 26, 2025
Abstract
Multiple
myeloma
(MM)
is
a
hematological
malignancy
defined
by
the
abnormal
proliferation
and
accumulation
of
plasma
cells
(PC)
within
bone
marrow
(BM).
While
multiple
impacts
bone,
it
not
classified
as
primary
cancer.
The
microenvironment
significantly
influences
progression
its
treatment
response.
Mesenchymal
stromal
(MSCs)
in
this
environment
engage
with
other
components
via
direct
contact
secretion
soluble
factors.
This
review
examines
established
roles
MSCs
facets
MM
pathology,
encompassing
their
pro-inflammatory
functions,
contributions
to
tumor
epigenetics,
effects
on
immune
checkpoint
inhibitors
(ICIs),
influence
reprogramming,
chemotherapy
resistance,
senescence.
investigates
role
development
MM.
Language: Английский